The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells T Nechiporuk, SE Kurtz, O Nikolova, T Liu, CL Jones, A D'Alessandro, ... Cancer discovery 9 (7), 910-925, 2019 | 305 | 2019 |
An expanded universe of cancer targets WC Hahn, JS Bader, TP Braun, A Califano, PA Clemons, BJ Druker, ... Cell 184 (5), 1142-1155, 2021 | 174 | 2021 |
Using interdisciplinary bioinformatics undergraduate research to recruit and retain computer science students J Beck, B Buckner, O Nikolova ACM SIGCSE Bulletin 39 (1), 358-361, 2007 | 44 | 2007 |
CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network BA Aksoy, V Dančík, K Smith, JN Mazerik, Z Ji, B Gross, O Nikolova, ... Database 2017, bax054, 2017 | 32 | 2017 |
Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer C Xu, O Nikolova, RS Basom, RM Mitchell, R Shaw, RD Moser, H Park, ... Clinical Cancer Research 24 (12), 2828-2843, 2018 | 28 | 2018 |
The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 2019; 9: 910–925. doi: 10.1158/2159-8290 T Nechiporuk, SE Kurtz, O Nikolova, T Liu, CL Jones, A D’alessandro, ... CD-19-0125.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 28 | |
Involving undergraduates in the annotation and analysis of global gene expression studies: creation of a maize shoot apical meristem expression database B Buckner, J Beck, K Browning, A Fritz, L Grantham, E Hoxha, Z Kamvar, ... Genetics 176 (2), 741-747, 2007 | 27 | 2007 |
Parallel globally optimal structure learning of Bayesian networks O Nikolova, J Zola, S Aluru Journal of Parallel and Distributed Computing 73 (8), 1039-1048, 2013 | 24 | 2013 |
Parallel Bayesian network structure learning with application to gene networks O Nikolova, S Aluru SC'12: Proceedings of the International Conference on High Performance …, 2012 | 18 | 2012 |
Parallel discovery of direct causal relations and markov boundaries with applications to gene networks O Nikolova, S Aluru 2011 International Conference on Parallel Processing, 512-521, 2011 | 15 | 2011 |
A parallel algorithm for exact Bayesian network inference O Nikolova, J Zola, S Aluru 2009 International Conference on High Performance Computing (HiPC), 342-349, 2009 | 15 | 2009 |
The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 2019; 9 (7): 910–925. doi: 10.1158/2159-8290 T Nechiporuk, SE Kurtz, O Nikolova, T Liu, CL Jones, A D'Alessandro, ... CD-19-0125.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 15 | |
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia SE Kurtz, CA Eide, A Kaempf, N Long, D Bottomly, O Nikolova, BJ Druker, ... Blood Advances 6 (10), 3062-3067, 2022 | 13 | 2022 |
The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 9, 910–925 T Nechiporuk, SE Kurtz, O Nikolova, T Liu, CL Jones, A D’Alessandro, ... | 11 | 2019 |
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies O Nikolova, R Moser, C Kemp, M Gonen, AA Margolin Bioinfromatics, 2017 | 11 | 2017 |
Transforming Big Data into cancer-relevant insight: an initial, multi-tier approach to assess reproducibility and relevance Cancer Target Discovery and Development Network Molecular Cancer Research 14 (8), 675-682, 2016 | 7 | 2016 |
The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 2019; 9: 910–25. doi: 10.1158/2159-8290 T Nechiporuk, SE Kurtz, O Nikolova, T Liu, CL Jones, A D’Alessandro CD-19-0125.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 6 | |
Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma R Moser, KE Gurley, O Nikolova, G Qin, R Joshi, E Mendez, I Shmulevich, ... Oncogene 41 (24), 3355-3369, 2022 | 5 | 2022 |
A parallel algorithm for exact Bayesian structure discovery in Bayesian networks Y Chen, J Tian, O Nikolova, S Aluru arXiv preprint arXiv:1408.1664, 2014 | 4 | 2014 |
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL R Moser, J Annis, O Nikolova, C Whatcott, K Gurley, E Mendez, ... Cancer research 82 (18), 3375-3393, 2022 | 3 | 2022 |